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Abstract
Background: Papillary fibroelastomas are rare, benign cardiac tumors that are often found on cardiac valvular
surfaces. Most are incidental discoveries during surgery or autopsy. The clinical presentation of fibroelastoma varies
widely, ranging from clinically asymptomatic to severe thromboembolic events.
Case presentation: We report a case of 65-year-old white man diagnosed with scattered, bilateral acute cerebral
hemisphere infarcts with a history of chronic angina. Transesophageal echocardiography identified a fibroelastoma
on the right coronary cusp of the aortic leaflet. Cardiac catheterization revealed mild non-obstructive stenosis. We
postulate that the etiology of his angina is related to the dynamic occlusion of his right coronary ostium by the
fibroelastoma.
Conclusions: To the best of our knowledge, this is the first case report describing a patient with a cardiac papillary
fibroelastoma who presented with both chronic angina and acute stroke.
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Background
Papillary fibroelastoma (PFE) is the second most common
benign primary tumor of the heart [1]. The clinical pres-
entation of PFEs varies widely, ranging from primarily
asymptomatic to severe ischemia with embolic events.
PFEs usually involve the cardiac valves and are now being
recognized more frequently with the aid of transesopha-
geal echocardiography (TEE). Symptomatic cardiac PFEs
and asymptomatic, mobile left-sided lesions greater than 1
cm in diameter should be evaluated for surgical excision
[2]. There is an excellent postoperative prognosis with no
recurrences having been reported to date. We describe a
rare case of a 65-year-old man, with a history of chronic
angina, who presented with an acute stroke and was inci-
dentally found to have a PFE on the right coronary cusp
of the aortic leaflet.
Case presentation
A 65-year-old white man with a history of hyperlipid-
emia, hypertension, and chronic angina, presented with
a sudden onset left-sided visual field deficit with left
upper extremity weakness. The symptoms started
abruptly while he was working at his computer. On ar-
rival at an Emergency Department (ED), his visual symp-
toms had resolved, but he still had residual weakness
and difficulty coordinating his left upper extremity. A
physical examination revealed a body mass index (BMI)
of 40.5 kg/m2, blood pressure of 147/82 mmHg, partial
left-sided hemianopia, 4/5 strength in left arm/hand with
pronator drift, and normal heart sounds. A chest X-ray
revealed a mildly enlarged cardiac silhouette. Computed
tomography (CT) of his head without contrast was unre-
markable. His National Institutes of Health Stroke Scale
(NIHSS) was 3 and he was within the 3-hour window,
thus tissue plasminogen activator (tPA) was given with-
out delay. However, his symptoms did not improve. He
denied any similar prior episodes or any family history* Correspondence: fzhang8886@gmail.com1Department of Internal Medicine, Brookdale University Hospital and Medical
Center, One Brookdale Plaza, Brooklyn, NY 11212, USA
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of premature coronary artery disease and/or stroke. He
had a previous cardiac stress test which was negative.
Further workup with magnetic resonance imaging
(MRI) of his brain discovered small, scattered, bilateral,
cortically based acute infarcts with a distribution pat-
tern suggestive of an embolic event. The scattered areas
had T2 hyperintensities in the right frontal, parietal,
and occipital regions, all with associated diffusion and
apparent diffusion coefficient (ADC) map abnormalities
(Fig. 1). Transthoracic echocardiography (TTE) noted a
small rounded echodensity on the right coronary cusp
of the aortic leaflet. Repeat TEE reported structurally
normal aortic valves with a round, pedunculated mobile
mass measuring approximately 11×15 mm, attached to
the right coronary leaflet (Fig. 2). The appearance of
the mass was characteristic of a PFE. Prior to surgical
removal of his PFE, our patient underwent left-sided
cardiac catheterization owing to his history of angina
and multiple surgical risk factors. The results of which
revealed normal coronary arteries except for mild lu-
minal irregularities with proximal and mid-segment
stenosis (20%) of his left anterior descending (LAD) ar-
tery. He eventually underwent a bioprosthetic aortic
valve replacement with excision of the leaflets and
mass. The mass was soft, pink-yellow in color, and
measured 1.3×1.0×0.7 cm. It had narrow, elongated
papillary fronds and a hyalinized central core sur-
rounded by flat endocardial lining. Pathology results
confirmed PFE with myxoid degenerative changes
(Fig. 3). He developed transient postoperative atrial fib-
rillation which was initially controlled by amiodarone
before reverting to a normal sinus rhythm. He was dis-
charged to short-term rehabilitation and has made a
successful recovery.
Discussion
PFEs are rare cardiac tumors with a prevalence of 0.002 to
0.28% among the general population [3]. The average age
at diagnosis is 56, with a primarily male preponderance
(58%) [4]. As a primarily benign endocardial tumor, most
are reported because of advances in clinical imaging. PFEs
are the most common valvular tumors of the heart, ac-
counting for 10% of all cardiac primary neoplasms [1].
Clinical presentation varies depending on the location, di-
mensions, growth rate, mobility, and tendency for
embolization. The masses are generally asymptomatic and
are discovered incidentally during surgery and/or autopsy.
Even though PFEs are histologically benign, they can re-
sult in serious complications. The most common clinical
manifestation of a symptomatic fibroelastoma is a
Fig. 1 Magnetic resonance imaging of the brain. Scattered bilateral cerebral hemispheric small cortical-based acute infarcts (arrows) with a distribution
suggestive of embolic phenomenon and alternatively watershed regions, including right occipital (a, c), left occipital (a), right frontal (b), and
right parietal lobes (d)
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transient ischemic attack and/or stroke [5]. Other mani-
festations include cardiac angina, myocardial infarction,
sudden cardiac death, heart failure, presyncope or syn-
cope, pulmonary embolism, blindness, mesenteric ische-
mia, peripheral emboli, and renal infarction.
Cardiac PFEs arise most often from the left side of the
heart, frequently in clinical association with hyperten-
sion. They have a high propensity to affect the aortic
valve (44%), the left ventricular outflow tract and the an-
terior mitral leaflet (35%). However, PFEs have been ob-
served on all valves (84%), and even with occasional
formation within the mural endocardium [1]. Single or
multiple lesions can develop. Among patients with aortic
valve tumors, sudden death and myocardial infarction
were the two most common outcomes [6]. The mitral
valve was reported to be the most common source of
systemic tumor embolization, such as in stroke [7].
Rarely, when present on the aortic valve, PFEs may
cause angina by transiently occluding the coronary ostia
and/or by embolizing into the coronary arteries. In our
case, the patient presented with both stroke and angina.
PFEs affect coronary artery blood flow and can
present as exertional chest pain, suggestive of chronic
angina [7], or acute coronary syndrome [8]. Of interest,
Fig. 2 Transesophageal echocardiography. a, b Transesophageal echocardiography in the mid-esophageal view of aortic valve at long axis
revealed a mobile mass 11×15 mm in diameter attached to the right leaflet of the aortic valve. It partially prolapsed in the left ventricular
outflow tract of the aorta. c, d Mid-esophageal aortic valve short axis view of the papillary fibroelastoma attached to the aortic side of
the right coronary cusp
Fig. 3 Hematoxylin and eosin stain of the papillary fibroelastoma with narrow elongated and branching papillary fronds formed by central
avascular collagen and elastic tissue core and the flat endocardial lining (left panel view, 2× magnification; right panel, 10× magnification)
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in cases where PFEs affected coronary artery blood
flow, the PFEs were found to be attached to the right
coronary cusp. The aortic valve has three cusps: left,
right, and non-coronary. The ostium of the right coron-
ary artery is found above the right coronary cusp. The
ostium of the left main coronary artery is found mid-
way between the commissures of the left coronary cusp,
while the non-coronary cusp is positioned posteriorly.
PFEs usually present as mobile ball-like tumors located
at the top of the right coronary cusp. They often con-
tain pedicles with multiple papillary fronds which vary
in dimensions ranging from 2 to 50 mm in length. In
our case, the patient had a history of chronic angina
with a prior work up including a negative nuclear stress
test as well as a cardiac catheterization revealing insig-
nificant stenosis. Therefore, the chronic angina was
probably due to transient obstruction of the coronary
ostia by PFEs located on the right coronary cusp.
Structurally, PFEs resemble chordae tendineae. They are
avascular tumors composed of an outer endothelial layer,
and a dense central core composed of a rim of loose
mucopolysaccharide-rich connective tissue, dendritic cells,
fibroblasts, and smooth muscle cells [1]. On gross examin-
ation, PFEs appear to have multiple frond-like projections
that look like sea anemone attached to the endocardium
[3]. The matrix consists of proteoglycans and prominent
elastic fibers that form a concentric pattern, contiguous
with the underlying valve leaflet, which was confirmed
with immunohistochemical staining [9].
The high embolic potential of PFEs is due to the fri-
ability of their tissue matrix in addition to their extreme
mobility within the aortic root. The intermittent dis-
lodgement of papillary frond fragments and/or the plate-
let/fibrin thrombi formed on them may lead to
thromboembolic events, such as in acute coronary syn-
drome and cerebrovascular accidents (CVAs) [10].
The exact mechanisms leading to the development of
PFEs are still unclear. There are several hypotheses
involving organizing thrombi, congenital hamartomas,
iatrogenic formations, cytomegalovirus infection, rheum-
atic valve disease, as well as true primary neoplasms
[11]. The most widely accepted explanation is that of the
microthrombus theory. This presumes that the tumor is
formed by minor endothelial damage on the margins of
the valves, which serves as a nidus for the growth and
progression of microthrombi. These then coalesce into
overgrowths similar to those of Lambl’s excrescences
[12]. However, unlike Lambl’s excrescences, which
localize at valvular closing lines and the free edges of
valve cusps, PFEs are found on any type of endocardial
tissue. PFEs can grow to diameters of up to 1 to 5 cm,
compared to Lambl’s excrescences which are much
smaller [13]. This theory is also supported by the loca-
tion of PFEs on non-valvular endocardial surfaces close
to prior cardiac procedure sites or radiation fields up to
18 years later [14].
It is important to differentiate PFEs from cardiac myx-
omas and thrombi because of the differences in their
medical treatment. A clear surgical margin is necessary
for the excision of a myxoma due to its high rate of re-
currence. On the other hand, fibroelastomas rarely recur
after resection, thus it is recommended to preserve
valvular function by shaving off the tumor [15]. Al-
though TTE is widely used to screen for PFEs, TEE is
more sensitive and can provide higher resolution im-
aging for surgical planning and intraoperative guidance,
which lead to changes in management in 16.7% of pa-
tients with suspected cardioembolic stroke [13].
On echocardiography, PFEs typically appear as
homogenous speckled, round, mobile, pedunculated or
sessile masses, mostly located on cardiac valves [16]. In
contrast, myxomas are heterogenous masses with broad-
based pedicles and little mobility, predominately in the
left atrium [17]. Lambl’s excrescences are more numer-
ous, smaller, and broader-based lesions located near the
lines of valvular closure [1]. Although thrombi can be
differentiated by their irregular shape, laminated appear-
ance and absence pedicles [18], native aortic valve
thrombi often resemble PFEs, which can lead to un-
necessary surgical interventions [16]. Bacterial vegeta-
tions are more irregular in appearance [19]. The
development of cardiovascular magnetic resonance
(CMR) and multidetector-row CT (MDCT) as tools in
the evaluation of soft tissue masses of the heart is cur-
rently under investigation.
PFEs carry a very high risk of thromboembolic compli-
cations including CVA and cardiac events, such as in
this case. The only independent predictor of PFEs-
related deaths and/or nonfatal embolizations is tumor
mobility. Asymptomatic immobile tumors with diame-
ters less than 1 cm can be followed closely by clinical
evaluation and echocardiography. While urgent surgical
resection is recommended for all symptomatic patients
who have mobile pedunculated tumors that are increas-
ing in size. Surgical resection via a valve-sparing shave is
curative and safe. However, in the case of advanced car-
diac valve involvement, such as in our case, valve re-
placement should be considered. Among affected
patients, it has been reported that 83% were treated with
simple tumor resection, 9% with tumor resection and
valve repair, and 10% required prosthetic valve replace-
ment. Symptomatic patients who are not surgical candi-
dates may be observed closely and offered therapeutic
anticoagulation.
Conclusions
We report a rare case of a PFE located on the right cor-
onary cusp that is associated with both a CVA as well as
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chronic angina. These presentations are due to the mo-
bility and friability of the mass, which cause transient
occlusion of the right coronary orifice in addition to
intermittent dislodgement of papillary fragments. The
differential diagnosis includes cardiac myxoma, Lambl’s
excrescences, bacterial vegetations, and thrombi. Echo-
cardiography with TEE is more sensitive for guidance.
PFEs are resectable and carry an excellent postoperative
prognosis as well as a low recurrence rate. Long-term
cardiologic surveillance is recommended.
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